Next-generation sequencing is a technique for sequencing DNA or RNA that enables many reactions to be carried out simultaneously. NGS has transformed cancer genetics in recent years by providing researchers with access to genomic and transcriptomic data. In most of the developed nations the next generation sequencing method is used to develop cancer treatments through novel therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007163/
Clinical Oncology Next Generation Sequencing Market: Competitive Landscape and Key Developments:
- Agilent Technologies, Inc.
- Caris Life Sciences
- F. Hoffmann-La Roche Ltd
- FOUNDATION MEDICINE, INC.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Oxford Nanopore Technologies
- PerkinElmer Inc
- QIAGEN
- Thermo Fisher Scientific Inc.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876